Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003082192A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003082189A2 Method for producing pseudo islets
10/09/2003WO2003045328A3 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
10/09/2003WO2003032923A3 Induction of beta cell differentiation in human cells
10/09/2003WO2003022994A3 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
10/09/2003WO2003013604A3 Migenix agonists and antagonists for use in the treatment of metabolic disorders
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003006893A3 Methods of inhibiting amyloid toxicity
10/09/2003WO2003005959A3 Amphiphilic star-like macromolecules for drug delivery
10/09/2003WO2003004040A8 Dietetic preparation with hypocholesterolemic activity
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083936A3 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003US20030191323 An acylsulfonamide derivatives having insulin resistance, used as enzyme inhibitor of acetyl CoA carboxylase, preventing and curing diabetes
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191174 Novel bicyclic compounds
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191161 Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191136 Melanin concentrating hormone receptor ligands
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191104 Therapy for carbohydrate metabolism disorders
10/09/2003US20030191103 Hormone replacement therapy
10/09/2003US20030191097 Hormone replacement therapy
10/09/2003US20030191093 Pharmaceutical compositions comprising active vitamin D compounds
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030191056 Immobilization onto polyoxyethylene glycol
10/09/2003US20030191043 Methods and formulations for enhancing the dissolution of a solid material in liquid
10/09/2003US20030190733 Desaturase genes and uses thereof
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190607 Polymorphisms in human pyruvate dehydrogenase E1 beta (PDH E1 beta) gene; for analysing allelic variation; bioinformatic applications
10/09/2003US20030190597 For drug screening and development, exposing to a compound that paralyzes or kills nematoda
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190357 Compositions for delivery of a cortisol antagonist
10/09/2003US20030190284 Agglomerated particles for aerosol drug delivery
10/09/2003CA2481258A1 Antidiabetic agents
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003CA2480634A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479915A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2474512A1 Method for producing pseudo islets
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350516A1 Compositions for preventing or ameliorating multiple risk factor syndromes
10/08/2003EP1349964A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349865A2 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349855A1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349579A1 IMPROVED SOLUBILITY AND DISPERSIBILITY BY EXPOSURE TO O x?
10/08/2003EP1349578A2 Medicinal association of a biguanine (metformin) and arginine
10/08/2003EP1349563A2 Peptide yy and peptide yy agonists for treatment of metabolic disorders
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1349531A1 Spaced drug delivery system
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1165119B1 Composition based on oppositely-charged polypeptides
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
1 ... 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 ... 1298